Those negatives have largely always been a feature... the most visible hope for DECN at this point is GenViro. Even if they miraculously get one working test, by the time it gets to market, the number of competitors will be in the dozens.. some will be cheaper, some will be just as fast, some will not even require a meter. Proper precautions and use of those meters to keep a watch on at-risk people should have a drastic and positive effect on spread, but a negative effect on the testing market. 520 million tests... I think not.

The above is 100% pie-in-the-Sky optimistic.. the reality / likelihood is much grimmer.